Angiotensin II Infusion for Shock: A Multicenter Study of Postmarketing Use

BACKGROUND: Vasodilatory shock refractory to catecholamine vasopressors and arginine vasopressin is highly morbid and responsible for significant mortality. Synthetic angiotensin II is a potent vasoconstrictor that may be suitable for use in these patients. RESEARCH QUESTION: What is the safety and...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Chest
Hlavní autoři: Wieruszewski, Patrick M., Wittwer, Erica D., Kashani, Kianoush B., Brown, Daniel R., Butler, Simona O., Clark, Angela M., Cooper, Craig J., Davison, Danielle L., Gajic, Ognjen, Gunnerson, Kyle J., Tendler, Rachel, Mara, Kristin C., Barreto, Erin F.
Médium: Artigo
Jazyk:Inglês
Vydáno: American College of Chest Physicians 2021
Témata:
Critical Care: Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7856533/
https://ncbi.nlm.nih.gov/pubmed/32882250
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.chest.2020.08.2074
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky